WebThe generic name of Trikafta is elexacaftor, tezacaftor, and ivacaftor. The product's dosage form is kit. The product is distributed in a single package with assigned NDC code 51167-331-01 4 blister pack in 1 carton / 1 kit in 1 blister pack * 14 tablet, film coated in 1 blister pack (51167-431-14) * 7 tablet, film coated in 1 blister pack ... WebTrikafta ist angezeigt zur Behandlung von Patienten ab 6 Jahren mit zystischer Fibrose (CF) und mindestens einer F508del-Mutation im CFTR (Cystic Fibrosis Transmembrane Conductance Regulator)-Gen. Trikafta enthält drei Wirkstoffe: Elexacaftor, Tezacaftor und Ivacaftor. Die zystische Fibrose ist eine erbliche Erkrankung, die zu einer ...
Setting the record straight - Trikafta facts » Cystic Fibrosis NZ
Webyellowing of the skin or eyes. loss of appetite. nausea. vomiting. pale stools. stomach pain. dark urine. The combination of elexacaftor, tezacaftor, and ivacaftor may cause cataracts (clouding of the lens of the eye that may cause vision problems) in children and teenagers. Children and teenagers taking elexacaftor, tezacaftor, and ivacaftor ... WebIndications and Usage for TRIKAFTA ... Hormonal contraceptives, including oral, injectable, transdermal, and implantable, should not be relied upon as an effective method of contraception when co-administered with ORKAMBI; Strong CYP3A Inducers. Ivacaftor is a substrate of CYP3A4 and CYP3A5 isoenzymes. christine jordan wigs discontinued
Trikafta Interactions with Other Medication - WebMD
WebTrikafta is a transformational drug that has the potential to treat up to 90% of Canadians with cystic fibrosis. It is a triple combination precision medicine (ivacaftor, tezacaftor and elexacaftor). Rather than just treating symptoms, Trikafta targets the basic defect from specific genetic mutations that cause CF. WebThe incidence of rash events was higher in female patients treated with TRIKAFTA (16%) than in male patients treated with TRIKAFTA (5%) Hormonal contraceptives may play a role in the occurrence of rash. For patients taking hormonal contraceptives who develop rash, consider interrupting TRIKAFTA and hormonal contraceptives. WebJan 9, 2024 · The incidence of rash events was higher in female TRIKAFTA-treated patients (16%) than in male TRIKAFTA-treated patients (5%). Hormonal contraceptives may play a role in the occurrence of rash. For patients taking hormonal contraceptives who develop rash, consider interrupting TRIKAFTA and hormonal contraceptives. christine jordan obituary